Novocure Selling General Administrative from 2010 to 2024

NVCR Stock  USD 12.74  0.50  4.08%   
Novocure Selling General Administrative yearly trend continues to be relatively stable with very little volatility. Selling General Administrative is likely to drop to about 87.6 M. During the period from 2010 to 2024, Novocure Selling General Administrative destribution of quarterly values had range of 147.5 M from its regression line and mean deviation of  40,837,712. View All Fundamentals
 
Selling General Administrative  
First Reported
2013-12-31
Previous Quarter
41.9 M
Current Value
39.4 M
Quarterly Volatility
13 M
 
Yuan Drop
 
Covid
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 3.2 M or Selling General Administrative of 87.6 M, as well as many exotic indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0 or PTB Ratio of 4.16. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
  
This module can also supplement Novocure's financial leverage analysis and stock options assessment as well as various Novocure Technical models . Check out the analysis of Novocure Correlation against competitors.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Latest Novocure's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Novocure over the last few years. It is Novocure's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Novocure Selling General Administrative Regression Statistics

Arithmetic Mean67,590,980
Geometric Mean50,071,172
Coefficient Of Variation72.04
Mean Deviation40,837,712
Median59,114,000
Standard Deviation48,694,628
Sample Variance2371.2T
Range147.5M
R-Value0.91
Mean Square Error427.9T
R-Squared0.83
Slope9,934,410
Total Sum of Squares33196.3T

Novocure Selling General Administrative History

202487.6 M
2023164.1 M
2022132.8 M
2021126.1 M
2020107.4 M
201987.9 M
201873.5 M

About Novocure Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Novocure income statement, its balance sheet, and the statement of cash flows. Novocure investors use historical funamental indicators, such as Novocure's Selling General Administrative, to determine how well the company is positioned to perform in the future. Although Novocure investors may use each financial statement separately, they are all related. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Novocure's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Novocure Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Novocure. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative164.1 M87.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Novocure is a strong investment it is important to analyze Novocure's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Novocure's future performance. For an informed investment choice regarding Novocure Stock, refer to the following important reports:
Check out the analysis of Novocure Correlation against competitors.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.
Note that the Novocure information on this page should be used as a complementary analysis to other Novocure's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Novocure Stock analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is Novocure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novocure. If investors know Novocure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novocure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
(1.95)
Revenue Per Share
4.787
Quarterly Revenue Growth
0.042
Return On Assets
(0.12)
The market value of Novocure is measured differently than its book value, which is the value of Novocure that is recorded on the company's balance sheet. Investors also form their own opinion of Novocure's value that differs from its market value or its book value, called intrinsic value, which is Novocure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novocure's market value can be influenced by many factors that don't directly affect Novocure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novocure's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novocure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novocure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.